Literature DB >> 30405233

Gut reaction.

Michael Eisenstein.   

Abstract

Keywords:  Cell biology; Immunology; Microbiome

Mesh：

Year:  2018        PMID： 30405233     DOI： 10.1038/d41586-018-07277-1

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  7 in total

1.  Ulcerative colitis and colorectal cancer. A population-based study.

Authors:  A Ekbom; C Helmick; M Zack; H O Adami
Journal:  N Engl J Med       Date:  1990-11-01       Impact factor: 91.245

2.  The epidemiology of colectomy in ulcerative colitis: results from a population-based cohort.

Authors:  Laura E Targownik; Harminder Singh; Zoann Nugent; Charles N Bernstein
Journal:  Am J Gastroenterol       Date:  2012-05-22       Impact factor: 10.864

3.  Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial.

Authors:  Sudarshan Paramsothy; Michael A Kamm; Nadeem O Kaakoush; Alissa J Walsh; Johan van den Bogaerde; Douglas Samuel; Rupert W L Leong; Susan Connor; Watson Ng; Ramesh Paramsothy; Wei Xuan; Enmoore Lin; Hazel M Mitchell; Thomas J Borody
Journal:  Lancet       Date:  2017-02-15       Impact factor: 79.321

4.  Efficacy of Indigo Naturalis in a Multicenter Randomized Controlled Trial of Patients With Ulcerative Colitis.

Authors:  Makoto Naganuma; Shinya Sugimoto; Keiichi Mitsuyama; Taku Kobayashi; Naoki Yoshimura; Hidehisa Ohi; Shinji Tanaka; Akira Andoh; Naoki Ohmiya; Keiichiro Saigusa; Takayuki Yamamoto; Yuichi Morohoshi; Hitoshi Ichikawa; Katsuyoshi Matsuoka; Tadakazu Hisamatsu; Kenji Watanabe; Shinta Mizuno; Wataru Suda; Masahira Hattori; Shinji Fukuda; Akiyoshi Hirayama; Takayuki Abe; Mamoru Watanabe; Toshifumi Hibi; Yasuo Suzuki; Takanori Kanai
Journal:  Gastroenterology       Date:  2017-11-22       Impact factor: 22.682

5.  Fecal Microbiota Transplantation Induces Remission in Patients With Active Ulcerative Colitis in a Randomized Controlled Trial.

Authors:  Paul Moayyedi; Michael G Surette; Peter T Kim; Josie Libertucci; Melanie Wolfe; Catherine Onischi; David Armstrong; John K Marshall; Zain Kassam; Walter Reinisch; Christine H Lee
Journal:  Gastroenterology       Date:  2015-04-07       Impact factor: 22.682

6.  Maintaining remission of ulcerative colitis with the probiotic Escherichia coli Nissle 1917 is as effective as with standard mesalazine.

Authors:  W Kruis; P Fric; J Pokrotnieks; M Lukás; B Fixa; M Kascák; M A Kamm; J Weismueller; C Beglinger; M Stolte; C Wolff; J Schulze
Journal:  Gut       Date:  2004-11       Impact factor: 23.059

Review 7.  Novel Therapies and Treatment Strategies for Patients with Inflammatory Bowel Disease.

Authors:  Marjolijn Duijvestein; Robert Battat; Niels Vande Casteele; Geert R D'Haens; William J Sandborn; Reena Khanna; Vipul Jairath; Brian G Feagan
Journal:  Curr Treat Options Gastroenterol       Date:  2018-03
  7 in total
  6 in total

1.  Bletilla striata Oligosaccharides Improve Ulcerative Colitis by Regulating Gut Microbiota and Intestinal Metabolites in Dextran Sulfate Sodium-Induced Mice.

Authors:  Tianxiang Zhu; Baifei Hu; Cheng Ye; Haiming Hu; Mingzhu Yin; Zhigang Zhang; Shuiqing Li; Yanju Liu; Hongtao Liu
Journal:  Front Pharmacol       Date:  2022-04-25       Impact factor: 5.988

2.  Baicalein ameliorates ulcerative colitis by improving intestinal epithelial barrier via AhR/IL-22 pathway in ILC3s.

Authors:  Yan-Yang Li; Xiao-Jing Wang; Yu-Lin Su; Qing Wang; Shao-Wei Huang; Zeng-Feng Pan; Yan-Ping Chen; Jun-Jie Liang; Mei-Ling Zhang; Xue-Qian Xie; Zhi-Yun Wu; Jin-Yan Chen; Lian Zhou; Xia Luo
Journal:  Acta Pharmacol Sin       Date:  2021-10-20       Impact factor: 7.169

3.  GPA Peptide-Induced Nur77 Localization at Mitochondria Inhibits Inflammation and Oxidative Stress through Activating Autophagy in the Intestine.

Authors:  Zhao Deng; Qi Liu; Miaomiao Wang; Hong-Kui Wei; Jian Peng
Journal:  Oxid Med Cell Longev       Date:  2020-08-20       Impact factor: 6.543

4.  Inhibitor of Differentiation-2 Protein Ameliorates DSS-Induced Ulcerative Colitis by Inhibiting NF-κB Activation in Neutrophils.

Authors:  Jie Ren; Dong Yan; Yichun Wang; Jiaojiao Zhang; Min Li; Wancheng Xiong; Xueqian Jing; Puze Li; Weidong Zhao; Xiwen Xiong; Minna Wu; Genshen Zhong
Journal:  Front Immunol       Date:  2021-11-04       Impact factor: 7.561

5.  "Two-birds-one-stone" colon-targeted nanomedicine treats ulcerative colitis via remodeling immune microenvironment and anti-fibrosis.

Authors:  Jiaxin Zhang; Ante Ou; Xueping Tang; Rong Wang; Yujuan Fan; Yuefei Fang; Yuge Zhao; Pengfei Zhao; Dongying Chen; Bing Wang; Yongzhuo Huang
Journal:  J Nanobiotechnology       Date:  2022-08-30       Impact factor: 9.429

6.  GPA peptide inhibits NLRP3 inflammasome activation to ameliorate colitis through AMPK pathway.

Authors:  Zhao Deng; Jiangjin Ni; Xiaoyu Wu; Hongkui Wei; Jian Peng
Journal:  Aging (Albany NY)       Date:  2020-09-20       Impact factor: 5.682
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.